Related Experiment Video
Updated: Sep 13, 2025

08:38
Engineering Skeletal Muscle Tissues from Murine Myoblast Progenitor Cells and Application of Electrical Stimulation
Published on: March 19, 2013
21.2K
Engineering of tissue in microphysiological systems demonstrated by modelling skeletal muscle
Yuan Gao1, Zilin Zhang2, Yu Yao1
1Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100043, China.
Regenerative Biomaterials
|July 28, 2025
Summary
Advanced in vitro models like organoids and muscle-on-a-chip systems are improving skeletal muscle research. These technologies better mimic the muscle microenvironment, aiding studies on myogenesis and related diseases.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Regenerative Medicine
Background:
- Traditional in vitro models inadequately replicate skeletal muscle complexity.
- Insufficient reconstruction of the muscle microenvironment limits understanding of myogenesis.
- Physical cues and the extracellular matrix (ECM) are critical for muscle cell activity.
Purpose of the Study:
- To review advancements in creating functional skeletal muscle in vitro.
- To highlight microphysiological systems and innovative interventions for skeletal muscle modeling.
- To discuss the potential of these advanced models for disease research and therapeutic development.
Main Methods:
- Review of organoids and muscle-on-a-chip technologies.
- Analysis of bioprinting and electrical stimulation techniques.
- Focus on reconstructing the muscle tissue microenvironment.
Main Results:
- New models effectively restore functional skeletal muscle tissue in vitro.
- Advanced systems provide comprehensive, multi-scale data on muscle physiology.
- Improved precision in studying physiological and biochemical cues affecting muscle.
Conclusions:
- Organoids and muscle-on-a-chip represent significant progress in skeletal muscle modeling.
- These technologies enhance research into myogenesis, regeneration, and disease.
- Emerging applications include drug screening, disease modeling, and artificial tissue development.

